Antilipemic agent: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett |
imported>Meg Taylor (subpages) |
||
| Line 1: | Line 1: | ||
{{subpages}} | |||
In [[medicine]], '''antilipemic agents''' are [[medication]]s for the treatment of [[hypercholesterolemia]] and [[hypertriglyceridemia]].<ref>{{MeSH}}</ref> | In [[medicine]], '''antilipemic agents''' are [[medication]]s for the treatment of [[hypercholesterolemia]] and [[hypertriglyceridemia]].<ref>{{MeSH}}</ref> | ||
Revision as of 04:36, 30 September 2009
In medicine, antilipemic agents are medications for the treatment of hypercholesterolemia and hypertriglyceridemia.[1]
Classification
Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins)
Bile acid sequestrants
Fibric acid derivatives
Fibric acid derivatives include gemfibrozil, clofibrate, and fenofibrate. Fenofibrate is unique in being able to lower the serum uric acid level and treat hyperuricemia.[2]
Plant stanols
References
- ↑ Anonymous (2024), Antilipemic agent (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Feher MD, Hepburn AL, Hogarth MB, Ball SG, Kaye SA (February 2003). "Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout". Rheumatology (Oxford) 42 (2): 321–5. PMID 12595630. [e]